Consensus statement from European experts on the diagnosis, management, and treatment of multiple myeloma: from standard therapy to novel approaches. - Wikidata - awgldk - TriplyDB

Consensus statement from European experts on the diagnosis, management, and treatment of multiple myeloma: from standard therapy to novel approaches.

Consensus statement from European experts on the diagnosis, management, and treatment of multiple myeloma: from standard therapy to novel approaches.

http://www.wikidata.org/entity/Q37761370

about

Development of Novel Immunotherapies for Multiple Myeloma Galectin-3C inhibits tumor growth and increases the anticancer activity of bortezomib in a murine model of human multiple myeloma A Case of Drug-Induced Hepatitis due to Lenalidomide.Bortezomib administered subcutaneously is well tolerated in bortezomib-based combination regimens used in patients with multiple myeloma.Bortezomib in multiple myeloma: systematic review and clinical considerations.Global myeloma research clusters, output, and citations: a bibliometric mapping and clustering analysis The cost-effectiveness of initial treatment of multiple myeloma in the U.S. with bortezomib plus melphalan and prednisone versus thalidomide plus melphalan and prednisone or lenalidomide plus melphalan and prednisone with continuous lenalidomide mai Poor prognostic significance of Mycobacterium tuberculosis infection during bortezomib-containing chemotherapy in patients with multiple myeloma Economic evaluation of therapies for patients suffering from relapsed-refractory multiple myeloma in Greece.Challenges in multiple myeloma diagnosis and treatment.Enhancing cytokine-induced killer cell therapy of multiple myeloma.Chemotherapy-induced painful neuropathy: pain-like behaviours in rodent models and their response to commonly used analgesics European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma.European Myeloma Network: the 3rd Trialist Forum Consensus Statement from the European experts meeting on multiple myeloma.Autologous hematopoietic progenitor cell transplantation for multiple myeloma through an outpatient program.Allogeneic stem cell transplantation in multiple myeloma: immunotherapy and new drugs.Advances in current treatment for patients with newly diagnosed multiple myeloma.Characterization of a rat model of bortezomib-induced painful neuropathy.Symptom experience of multiple myeloma (syMMex) patients treated with autologous stem cell transplantation following high-dose melphalan: a descriptive longitudinal study.

P2860

Q28066890-1804A377-82B3-4301-944A-FB251AC80BE5 Q28742668-9F338B4B-9C5C-4F03-8BB1-10C4B1CF2B73 Q33395229-DA17DECE-DD44-47BF-84AC-A50C22F88828 Q33410637-78A16948-A758-40A1-8BAA-81F8536DD790 Q33982728-D0CB2812-21FA-483C-A6E4-330F9C5C23A8 Q35023376-00A95083-3BE2-4B6B-8153-5B7F92CEEF52 Q36565628-500D388C-2E3A-42F7-A8FB-602CFF559527 Q36761803-8CA48058-5486-4873-BB36-A6EF343C4F20 Q36768997-A12D8C89-1978-4374-AC3C-C740B26926D5 Q36852225-8DD82A74-A93B-467D-961E-BA3283165340 Q36892290-54282CCC-CEEF-411C-AB2B-CAFBD85F519E Q37170634-5F0F5FC0-50CE-440F-B275-09619ED5A4AC Q37552008-3DBBE3FC-CCF0-4741-929E-35A36562E930 Q37784220-97E252F3-0D1E-4F33-9852-CF4F7F129E41 Q38025703-78DDD81D-EA75-43A2-9FAE-2534DE1D6CE5 Q38417073-A612CB35-D822-4028-9346-EF1EE4DAD6F3 Q39769576-DB35A01A-C47C-4160-A34C-72F62D53339A Q47120603-8F498C95-649C-4FCB-B39A-487D6A4BB89A Q47636780-C324DC9E-860C-405B-8A82-E4BF4F4F5CC9

P2860

Consensus statement from European experts on the diagnosis, management, and treatment of multiple myeloma: from standard therapy to novel approaches.

http://www.wikidata.org/entity/Q37761370

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Consensus statement from Europ ...... d therapy to novel approaches.

@en

Consensus statement from Europ ...... d therapy to novel approaches.

@nl

type

label

Consensus statement from Europ ...... d therapy to novel approaches.

@en

Consensus statement from Europ ...... d therapy to novel approaches.

@nl

prefLabel

Consensus statement from Europ ...... d therapy to novel approaches.

@en

Consensus statement from Europ ...... d therapy to novel approaches.

@nl

P1433

Q37761370-E7C0E13A-DFA2-4E94-B4D4-EEBAF69556EB

P1476

Q37761370-3F88CBC7-6791-4535-9CAC-9DD12402302B

P2093

Q37761370-0159E1EC-916F-4BCF-A9AC-E416D76B9819

Q37761370-07E18409-3DE2-4C94-8946-0E0998C8BCB5

Q37761370-0C1E073B-F2D1-4B22-8E21-22F0C8BB9D32

Q37761370-2D5633BB-1A33-4F1D-8DF5-F15D6DB0917F

Q37761370-34592DDC-33AF-49FD-9E3B-76252C5915A4

Q37761370-4A9FE1E8-CB60-46D5-812A-EDE3A2141AF7

Q37761370-51CCE0A8-BEE9-41E0-9D11-ED7ECAE7F40F

Q37761370-6BBCD8BD-01AC-4A6B-A598-7423013F0F7A

Q37761370-73436D39-ED82-4D39-B5B9-EE6941B3662F

Q37761370-85F5B190-4A51-4F93-8F80-971925FD7834

P2860

Q37761370-0005C673-BD4C-4811-A22B-1987C04E4CF9

Q37761370-02087D02-0035-4956-9611-C6299F8B5E4E

Q37761370-0693C463-F304-4409-B084-D8CBA98DE8AD

Q37761370-0890672C-4F25-44CF-88EF-80921313767D

Q37761370-0AB9741B-A969-4479-A2DB-716F2D1B4228

Q37761370-0AE19172-D969-4E95-B084-545BBE0AF7C3

Q37761370-12250D43-494E-40AF-B522-3B613910BE9C

Q37761370-1BC4C48F-97C4-44B5-B146-FD747167E8DB

Q37761370-1C5E725C-E1BE-40C9-8C6E-3C1A4D62941C

Q37761370-1D54F81C-3934-45E5-BA9E-C29E96576DA1

P304

Q37761370-0088112C-471A-4AAB-B0E1-E3C288F34817

P31

Q37761370-E4CCDBD5-49BA-4CF9-90D2-451D34A4A03A

P356

Q37761370-FEB91E8E-7C77-4F68-A0F9-3F0A3EDCCD3D

P433

Q37761370-C1FE8216-6286-4D5D-8206-C1B595D16E05

P478

Q37761370-C02911F8-03AE-4D7B-970C-1CF80257F9B7

P50

Q37761370-04A5F5D7-2FBC-4B81-B14B-C0DC3D35C825

Q37761370-0C4C0148-77C9-44C6-9C79-581B936B8920

Q37761370-9F5D1BDC-C5B2-475F-BEBF-5DD3F6B536E4

Q37761370-C0CBB35D-8341-44A7-8974-03BD3F912359

Q37761370-EC9C8E43-6A01-4B1E-9DC4-A9CC618E0686

P577

Q37761370-27931311-4A34-4493-8128-75F3BCBCFFA8

P5875

Q37761370-8476607B-8D28-4AE6-8857-0E15D1535204

P698

Q37761370-2C6B5DD3-8315-47C3-8B61-B6359B86FCC5

P921

Q37761370-d1717837-6cfd-42b5-9c04-ed9878eb2497

P356

10428194.2010.487959

P1433

Leukemia & Lymphoma

P1476

Consensus statement from Europ ...... rd therapy to novel approaches

@en

P2093

Aaron Polliack

http://www.w3.org/2001/XMLSchema#string

Andrew Spencer

http://www.w3.org/2001/XMLSchema#string

Benedetto Bruno

http://www.w3.org/2001/XMLSchema#string

Christian Straka

http://www.w3.org/2001/XMLSchema#string

Donald Bunjes

http://www.w3.org/2001/XMLSchema#string

Fortunato Morabito

http://www.w3.org/2001/XMLSchema#string

Francesca Patriarca

http://www.w3.org/2001/XMLSchema#string

Josefina Udi

http://www.w3.org/2001/XMLSchema#string

Mario Boccadoro

http://www.w3.org/2001/XMLSchema#string

Martin Gramatzki

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of clonogenic multiple myeloma cells

Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study

MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis

Multiple myeloma

MicroRNA signatures in human cancers

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

Melphalan, prednisone, and lenalidomide treatment for newly diagnosed myeloma: a report from the GIMEMA--Italian Multiple Myeloma Network

Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws

Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial

Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial

P304

1424-1443

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10428194.2010.487959

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P50

Hermann Einsele

Antonio Palumbo

P577

2010-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44637294

http://www.w3.org/2001/XMLSchema#string

P698

20509769

http://www.w3.org/2001/XMLSchema#string

P921